Shimadzu System Combines HPLC and UHPLC Methods
PTSM: Pharmaceutical Technology Sourcing and Management
The Nexera-i MT from Shimadzu incorporates two flow lines, which allow for both UHPLC and HPLC analysis.
The Nexera-i MT from Shimadzu supports the transfer of existing high-performance liquid chromatography (HPLC) to faster ultra-high pressure liquid chormatography (UHPLC) methods while assuring cross-compatibility. The system’s analytical conditions transfer and optimization (ACTO) technology minimizes the effect of system volume differences on analytical results. The ACTO technology adjusts injection timing based on the system volume difference between existing HPLC system and Nexera-i MT without modification to the gradient program.
The Nexera-i MT features two independent flow lines, for UHPLC and HPLC analyses. The system can switch between flow lines and automatically compensates for differences in system volume, preserving relative separation patterns. It also allows for efficient switching between large- and small-volume systems. Users can transfer UHPLC and HPLC methods from other systems to the Nexera-i MT without the need for modification. The system includes fully automated system startup, baseline stabilization, and user interfaces. Users can modify analytical methods using the Nexera-i MT’s touchscreen control panel.
Source: Shimadzu
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
